T-Cell Immunotherapy Market, Global Outlook and Forecast 2022-2028

February 2022 | 66 pages | ID: TFD033CC8D39EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of T-Cell Immunotherapy in Global, including the following market information:

Global T-Cell Immunotherapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global T-Cell Immunotherapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

CAR-T Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of T-Cell Immunotherapy include Adaptimmune, Altor Bioscience Corporation, Cellectis, Juno Therapeutics, Kite Pharma, Novartis, Takara Bio and Unum Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the T-Cell Immunotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global T-Cell Immunotherapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global T-Cell Immunotherapy Market Segment Percentages, by Type, 2021 (%)

• CAR-T
• TCR
• TIL Therapies

Global T-Cell Immunotherapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global T-Cell Immunotherapy Market Segment Percentages, by Application, 2021 (%)

• Stomach Cancer
• Lung Cancer
• Colorectal Cancer
• Esophagus Cancer
• Pancreatic Cancer
• Others

Global T-Cell Immunotherapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global T-Cell Immunotherapy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies T-Cell Immunotherapy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies T-Cell Immunotherapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Adaptimmune
• Altor Bioscience Corporation
• Cellectis
• Juno Therapeutics
• Kite Pharma
• Novartis
• Takara Bio
• Unum Therapeutics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 T-Cell Immunotherapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global T-Cell Immunotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL T-CELL IMMUNOTHERAPY OVERALL MARKET SIZE

2.1 Global T-Cell Immunotherapy Market Size: 2021 VS 2028
2.2 Global T-Cell Immunotherapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top T-Cell Immunotherapy Players in Global Market
3.2 Top Global T-Cell Immunotherapy Companies Ranked by Revenue
3.3 Global T-Cell Immunotherapy Revenue by Companies
3.4 Top 3 and Top 5 T-Cell Immunotherapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies T-Cell Immunotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 T-Cell Immunotherapy Players in Global Market
  3.6.1 List of Global Tier 1 T-Cell Immunotherapy Companies
  3.6.2 List of Global Tier 2 and Tier 3 T-Cell Immunotherapy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global T-Cell Immunotherapy Market Size Markets, 2021 & 2028
  4.1.2 CAR-T
  4.1.3 TCR
  4.1.4 TIL Therapies
4.2 By Type - Global T-Cell Immunotherapy Revenue & Forecasts
  4.2.1 By Type - Global T-Cell Immunotherapy Revenue, 2017-2022
  4.2.2 By Type - Global T-Cell Immunotherapy Revenue, 2023-2028
  4.2.3 By Type - Global T-Cell Immunotherapy Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global T-Cell Immunotherapy Market Size, 2021 & 2028
  5.1.2 Stomach Cancer
  5.1.3 Lung Cancer
  5.1.4 Colorectal Cancer
  5.1.5 Esophagus Cancer
  5.1.6 Pancreatic Cancer
  5.1.7 Others
5.2 By Application - Global T-Cell Immunotherapy Revenue & Forecasts
  5.2.1 By Application - Global T-Cell Immunotherapy Revenue, 2017-2022
  5.2.2 By Application - Global T-Cell Immunotherapy Revenue, 2023-2028
  5.2.3 By Application - Global T-Cell Immunotherapy Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global T-Cell Immunotherapy Market Size, 2021 & 2028
6.2 By Region - Global T-Cell Immunotherapy Revenue & Forecasts
  6.2.1 By Region - Global T-Cell Immunotherapy Revenue, 2017-2022
  6.2.2 By Region - Global T-Cell Immunotherapy Revenue, 2023-2028
  6.2.3 By Region - Global T-Cell Immunotherapy Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America T-Cell Immunotherapy Revenue, 2017-2028
  6.3.2 US T-Cell Immunotherapy Market Size, 2017-2028
  6.3.3 Canada T-Cell Immunotherapy Market Size, 2017-2028
  6.3.4 Mexico T-Cell Immunotherapy Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe T-Cell Immunotherapy Revenue, 2017-2028
  6.4.2 Germany T-Cell Immunotherapy Market Size, 2017-2028
  6.4.3 France T-Cell Immunotherapy Market Size, 2017-2028
  6.4.4 U.K. T-Cell Immunotherapy Market Size, 2017-2028
  6.4.5 Italy T-Cell Immunotherapy Market Size, 2017-2028
  6.4.6 Russia T-Cell Immunotherapy Market Size, 2017-2028
  6.4.7 Nordic Countries T-Cell Immunotherapy Market Size, 2017-2028
  6.4.8 Benelux T-Cell Immunotherapy Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia T-Cell Immunotherapy Revenue, 2017-2028
  6.5.2 China T-Cell Immunotherapy Market Size, 2017-2028
  6.5.3 Japan T-Cell Immunotherapy Market Size, 2017-2028
  6.5.4 South Korea T-Cell Immunotherapy Market Size, 2017-2028
  6.5.5 Southeast Asia T-Cell Immunotherapy Market Size, 2017-2028
  6.5.6 India T-Cell Immunotherapy Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America T-Cell Immunotherapy Revenue, 2017-2028
  6.6.2 Brazil T-Cell Immunotherapy Market Size, 2017-2028
  6.6.3 Argentina T-Cell Immunotherapy Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa T-Cell Immunotherapy Revenue, 2017-2028
  6.7.2 Turkey T-Cell Immunotherapy Market Size, 2017-2028
  6.7.3 Israel T-Cell Immunotherapy Market Size, 2017-2028
  6.7.4 Saudi Arabia T-Cell Immunotherapy Market Size, 2017-2028
  6.7.5 UAE T-Cell Immunotherapy Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Adaptimmune
  7.1.1 Adaptimmune Corporate Summary
  7.1.2 Adaptimmune Business Overview
  7.1.3 Adaptimmune T-Cell Immunotherapy Major Product Offerings
  7.1.4 Adaptimmune T-Cell Immunotherapy Revenue in Global Market (2017-2022)
  7.1.5 Adaptimmune Key News
7.2 Altor Bioscience Corporation
  7.2.1 Altor Bioscience Corporation Corporate Summary
  7.2.2 Altor Bioscience Corporation Business Overview
  7.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Major Product Offerings
  7.2.4 Altor Bioscience Corporation T-Cell Immunotherapy Revenue in Global Market (2017-2022)
  7.2.5 Altor Bioscience Corporation Key News
7.3 Cellectis
  7.3.1 Cellectis Corporate Summary
  7.3.2 Cellectis Business Overview
  7.3.3 Cellectis T-Cell Immunotherapy Major Product Offerings
  7.3.4 Cellectis T-Cell Immunotherapy Revenue in Global Market (2017-2022)
  7.3.5 Cellectis Key News
7.4 Juno Therapeutics
  7.4.1 Juno Therapeutics Corporate Summary
  7.4.2 Juno Therapeutics Business Overview
  7.4.3 Juno Therapeutics T-Cell Immunotherapy Major Product Offerings
  7.4.4 Juno Therapeutics T-Cell Immunotherapy Revenue in Global Market (2017-2022)
  7.4.5 Juno Therapeutics Key News
7.5 Kite Pharma
  7.5.1 Kite Pharma Corporate Summary
  7.5.2 Kite Pharma Business Overview
  7.5.3 Kite Pharma T-Cell Immunotherapy Major Product Offerings
  7.5.4 Kite Pharma T-Cell Immunotherapy Revenue in Global Market (2017-2022)
  7.5.5 Kite Pharma Key News
7.6 Novartis
  7.6.1 Novartis Corporate Summary
  7.6.2 Novartis Business Overview
  7.6.3 Novartis T-Cell Immunotherapy Major Product Offerings
  7.6.4 Novartis T-Cell Immunotherapy Revenue in Global Market (2017-2022)
  7.6.5 Novartis Key News
7.7 Takara Bio
  7.7.1 Takara Bio Corporate Summary
  7.7.2 Takara Bio Business Overview
  7.7.3 Takara Bio T-Cell Immunotherapy Major Product Offerings
  7.7.4 Takara Bio T-Cell Immunotherapy Revenue in Global Market (2017-2022)
  7.7.5 Takara Bio Key News
7.8 Unum Therapeutics
  7.8.1 Unum Therapeutics Corporate Summary
  7.8.2 Unum Therapeutics Business Overview
  7.8.3 Unum Therapeutics T-Cell Immunotherapy Major Product Offerings
  7.8.4 Unum Therapeutics T-Cell Immunotherapy Revenue in Global Market (2017-2022)
  7.8.5 Unum Therapeutics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. T-Cell Immunotherapy Market Opportunities & Trends in Global Market
Table 2. T-Cell Immunotherapy Market Drivers in Global Market
Table 3. T-Cell Immunotherapy Market Restraints in Global Market
Table 4. Key Players of T-Cell Immunotherapy in Global Market
Table 5. Top T-Cell Immunotherapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global T-Cell Immunotherapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global T-Cell Immunotherapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies T-Cell Immunotherapy Product Type
Table 9. List of Global Tier 1 T-Cell Immunotherapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 T-Cell Immunotherapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global T-Cell Immunotherapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - T-Cell Immunotherapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - T-Cell Immunotherapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global T-Cell Immunotherapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - T-Cell Immunotherapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - T-Cell Immunotherapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global T-Cell Immunotherapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global T-Cell Immunotherapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global T-Cell Immunotherapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America T-Cell Immunotherapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe T-Cell Immunotherapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia T-Cell Immunotherapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America T-Cell Immunotherapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa T-Cell Immunotherapy Revenue, (US$, Mn), 2023-2028
Table 30. Adaptimmune Corporate Summary
Table 31. Adaptimmune T-Cell Immunotherapy Product Offerings
Table 32. Adaptimmune T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
Table 33. Altor Bioscience Corporation Corporate Summary
Table 34. Altor Bioscience Corporation T-Cell Immunotherapy Product Offerings
Table 35. Altor Bioscience Corporation T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
Table 36. Cellectis Corporate Summary
Table 37. Cellectis T-Cell Immunotherapy Product Offerings
Table 38. Cellectis T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
Table 39. Juno Therapeutics Corporate Summary
Table 40. Juno Therapeutics T-Cell Immunotherapy Product Offerings
Table 41. Juno Therapeutics T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
Table 42. Kite Pharma Corporate Summary
Table 43. Kite Pharma T-Cell Immunotherapy Product Offerings
Table 44. Kite Pharma T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
Table 45. Novartis Corporate Summary
Table 46. Novartis T-Cell Immunotherapy Product Offerings
Table 47. Novartis T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
Table 48. Takara Bio Corporate Summary
Table 49. Takara Bio T-Cell Immunotherapy Product Offerings
Table 50. Takara Bio T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
Table 51. Unum Therapeutics Corporate Summary
Table 52. Unum Therapeutics T-Cell Immunotherapy Product Offerings
Table 53. Unum Therapeutics T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. T-Cell Immunotherapy Segment by Type in 2021
Figure 2. T-Cell Immunotherapy Segment by Application in 2021
Figure 3. Global T-Cell Immunotherapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global T-Cell Immunotherapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global T-Cell Immunotherapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by T-Cell Immunotherapy Revenue in 2021
Figure 8. By Type - Global T-Cell Immunotherapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global T-Cell Immunotherapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global T-Cell Immunotherapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America T-Cell Immunotherapy Revenue Market Share, 2017-2028
Figure 12. US T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe T-Cell Immunotherapy Revenue Market Share, 2017-2028
Figure 16. Germany T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 17. France T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia T-Cell Immunotherapy Revenue Market Share, 2017-2028
Figure 24. China T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 28. India T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America T-Cell Immunotherapy Revenue Market Share, 2017-2028
Figure 30. Brazil T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa T-Cell Immunotherapy Revenue Market Share, 2017-2028
Figure 33. Turkey T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 37. Adaptimmune T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Altor Bioscience Corporation T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Cellectis T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Juno Therapeutics T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Kite Pharma T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Takara Bio T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Unum Therapeutics T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)